UASt regulatory sequences drive expression of an inverted repeat.
Expression of ActnGD1354 under the control of Scer\GAL4Mef2.PR causes larvae to develop more slowly than controls; newly-hatched (0-12 hour) larvae are smaller than controls, and, although their muscles have prominent Z-lines, some muscles appear to pull away from the attachment sites.
Adults expressing ActnGD1354 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression of ActnGD1354 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) results in viable flies or complete lethality, depending on the particular P{GD1354} insertion line used.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in early pupal lethality or late larval lethality.
Expression under the control of Scer\GAL4Mef2.PR results in split larval body wall muscles.
Expression under the control of Scer\GAL4Mef2.PR results in sarcomeres with reduced Z-lines in the larval body wall muscles.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 0% or 90-100% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 0% or 10-20% of the Scer\GAL4pnr-MD237-expressing area of the notum, depending on the insertion line used.
Expression of argosGD1666 under the control of Scer\GAL4ey.PH and Scer\GAL4GMR.PF leads to a mild rough eye phenotype.
ActnGD1354, Scer\GAL4Mef2.PR has some die during larval stage phenotype, enhanceable by Mlp84BGD6893, Scer\GAL4Mef2.PR
ActnGD1354, Scer\GAL4Mef2.PR has decreased body size | larval stage phenotype, enhanceable by Mlp84BGD6893, Scer\GAL4Mef2.PR
ActnGD1354, Scer\GAL4Mef2.PR has visible | larval stage phenotype, enhanceable by Mlp84BGD6893, Scer\GAL4Mef2.PR
ActnGD1354, Scer\GAL4Mef2.PR has some die during larval stage phenotype, enhanceable by Mlp84BPΔ8-95/Mlp84B[+]
ActnGD1354, Scer\GAL4GMR.PU is a non-enhancer of visible phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PU
ActnGD1354, Scer\GAL4GMR.PU is a non-suppressor of visible phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PU
ActnGD1354, Scer\GAL4GMR.PF, Scer\GAL4ey.PH has eye phenotype, enhanceable by Dcr-2UAS.cDa, Scer\GAL4GMR.PF, Scer\GAL4ey.PH
ActnGD1354 has muscle attachment site | larval stage phenotype, non-suppressible by Mlp84BGD6893/Scer\GAL4Mef2.PR
ActnGD1354, Scer\GAL4GMR.PU is a non-enhancer of eye phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PU
ActnGD1354, Scer\GAL4GMR.PU is a non-suppressor of eye phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PU
ActnGD1354, Mlp84BGD6893, Scer\GAL4Mef2.PR has Z disc | larval stage phenotype
Expression of Mlp84BGD6893 and ActnGD1354 under the control of Scer\GAL4Mef2.PR in larvae causes severe disruption of muscle structure, with some wispy muscle fibers, and Z-lines that are hard to discern; these phenotypes are not seen in controls or in either single knock-down.
Coexpression of Dcr-2Scer\UAS.cDa with ActnGD1354, under the control of Scer\GAL4ey.PH and Scer\GAL4GMR.PF, leads to an enhancement of the ActnGD1354 rough eye phenotype.